Market Research Logo

Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Multiple Sclerosis epidemiology, Multiple Sclerosis diagnosed patients, and Multiple Sclerosis treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Multiple Sclerosis derived from epidemiological analysis, percentage of patients diagnosed with Multiple Sclerosis, and percentage of patients treated with a therapy.

The study helps executives estimate Multiple Sclerosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Multiple Sclerosis prevalence, Multiple Sclerosis diagnosis rate, and Multiple Sclerosis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Multiple Sclerosis Patient Flow
  • Multiple Sclerosis Prevalence
  • Multiple Sclerosis Diagnosed Patients
  • Multiple Sclerosis Treated Patients


1. Multiple Sclerosis: Disease Definition
2. Multiple Sclerosis Patient Flow in Europe
2A. Multiple Sclerosis Prevalence in Europe
2B. Multiple Sclerosis Diagnosed Patients in Europe
2C. Multiple Sclerosis Treated Patients in Europe
3. Multiple Sclerosis Patient Flow in Germany
3A. Multiple Sclerosis Prevalence in Germany
3B. Multiple Sclerosis Diagnosed Patients in Germany
3C. Multiple Sclerosis Treated Patients in Germany
4. Multiple Sclerosis Patient Flow in France
4A. Multiple Sclerosis Prevalence in France
4B. Multiple Sclerosis Diagnosed Patients in France
4C. Multiple Sclerosis Treated Patients in France
5. Multiple Sclerosis Patient Flow in Spain
5A. Multiple Sclerosis Prevalence in Spain
5B. Multiple Sclerosis Diagnosed Patients in Spain
5C. Multiple Sclerosis Treated Patients in Spain
6. Multiple Sclerosis Patient Flow in Italy
6A. Multiple Sclerosis Prevalence in Italy
6B. Multiple Sclerosis Diagnosed Patients in Italy
6C. Multiple Sclerosis Treated Patients in Italy
7. Multiple Sclerosis Patient Flow in UK
7A. Multiple Sclerosis Prevalence in UK
7B. Multiple Sclerosis Diagnosed Patients in UK
7C. Multiple Sclerosis Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Multiple Sclerosis Patient Flow in Europe, 2016
Table 2: Multiple Sclerosis Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Multiple Sclerosis Patient Flow in Germany, 2016
Table 4: Multiple Sclerosis Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Multiple Sclerosis Patient Flow in France, 2016
Table 6: Multiple Sclerosis Patient Flow Forecast in France, 2016 - 2025
Table 7: Multiple Sclerosis Patient Flow in Spain, 2016
Table 8: Multiple Sclerosis Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Multiple Sclerosis Patient Flow in Italy, 2016
Table 10: Multiple Sclerosis Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Multiple Sclerosis Patient Flow in UK, 2016
Table 12: Multiple Sclerosis Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Multiple Sclerosis Patient Flow in Europe, 2016
Figure 2: Multiple Sclerosis Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Multiple Sclerosis Patient Flow in Germany, 2016
Figure 4: Multiple Sclerosis Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Multiple Sclerosis Patient Flow in France, 2016
Figure 6: Multiple Sclerosis Patient Flow Forecast in France, 2016 - 2025
Figure 7: Multiple Sclerosis Patient Flow in Spain, 2016
Figure 8: Multiple Sclerosis Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Multiple Sclerosis Patient Flow in Italy, 2016
Figure 10: Multiple Sclerosis Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Multiple Sclerosis Patient Flow in UK, 2016
Figure 12: Multiple Sclerosis Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report